癌症干细胞和瘤免疫微环境 (TIME):危险的交叉语音
1Medical Laboratory Technology Department, Beirut Arab University, Beirut, Lebanon.
Current molecular medicine
|January 9, 2025
概括
癌症干细胞 (CSCs) 通过逃避免疫反应来驱动瘤生长和复发. 了解CSC免疫逃避对于开发有效的癌症免疫疗法和预防瘤复发至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症干细胞生物学
背景情况:
- 癌症干细胞 (CSCs) 被认为是瘤开始,进展和复发的关键驱动因素.
- CSCs拥有强大的机制来抵抗先天和适应性抗瘤免疫反应.
- 细胞内核细胞积极调节瘤免疫微环境 (TIME),促进免疫逃避和瘤存活.
研究的目的:
- 综合审查癌症干细胞使用的免疫逃生机制.
- 要强调CSC如何操纵瘤免疫微环境 (TIME) 以自我保护.
- 为设计改进的癌症免疫疗法策略提供见解,以克服CSC介导的抗性.
主要方法:
- 对CSC及其与免疫系统相互作用的研究进行文献综述.
- 分析CSCs逃避免疫监视和攻击的机制.
- 在瘤微环境中对CSC驱动的免疫抑制信息的综合.
主要成果:
- CSCs积极抑制抗瘤免疫细胞,并促进前瘤免疫细胞活动.
- CSCs劫持免疫细胞,以创建一个保护屏蔽,防止免疫媒介的破坏.
- 目前的癌症免疫治疗策略往往无法解释CSC特定的免疫逃避策略.
结论:
- 准CSC免疫逃避途径对于提高免疫疗法的疗效至关重要.
- 克服CSC驱动的免疫抑制是减少瘤复发和改善患者结果的关键.
- 这一审查为开发下一代专门针对CSCs的免疫疗法提供了基础.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K


